Target intelligence / Profile preview

Enterovirus D68 P1 polyprotein (P1)

Target
P1
Molecular classification
Viral structural protein, Capsid protein
01

Overview

The Enterovirus D68 (EV-D68) P1 polyprotein is the precursor for the structural proteins (VP1, VP2, VP3, and VP4) that assemble to form the viral capsid (UniProt: A0A075I070). During the viral life cycle, the P1 polyprotein is cleaved by the viral 3C protease into individual subunits that organize into an icosahedral shell, which protects the viral RNA genome and facilitates host cell recognition (PubMed: 25554783). EV-D68 is a significant respiratory pathogen that has been increasingly linked to outbreaks of acute flaccid myelitis (AFM), a serious condition characterized by sudden limb weakness and permanent paralysis (CDC). The P1 polyprotein, specifically the VP1 subunit, contains a hydrophobic pocket that is a major target for small-molecule antiviral drugs known as capsid inhibitors, such as pleconaril and pocapavir (PubMed: 26116709). These drugs function by binding within the pocket, thereby stabilizing the capsid and preventing the conformational changes necessary for the virus to release its genome into the host cell (PubMed: 25554783). Furthermore, the P1 polyprotein is the primary target for the development of neutralizing antibodies and vaccines, as it constitutes the outer surface of the infectious virion.

Other names
Capsid protein P1Structural polyprotein P1EV-D68 P1 precursorP1 structural precursor
02

Mechanism of action

Capsid stabilization and inhibition of viral uncoating by binding to the hydrophobic pocket of the VP1 subunit.

03

Biological functions

Viral assemblyViral entryHost cell attachmentCapsid formationViral uncoating
04

Disease associations

Respiratory infectionAcute flaccid myelitisInfection
05

Safety considerations

Emergence of drug-resistant viral variantsLimited clinical efficacy in late-stage infectionPotential for cross-reactivity with other enteroviruses
06

Interacting drugs

Pleconaril

2 more in the full profile.

07

Biomarkers

EV-D68 VP1 sequenceViral RNA loadNeutralizing antibody titer

Beyond the preview

Go deeper on Enterovirus D68 P1 polyprotein (P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enterovirus D68 P1 polyprotein (P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call